Frontiers | Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Rational design of inhibitors that bind to inactive kinase conformations | Nature Chemical Biology
Identification and Validation of Small-Gatekeeper Kinases as Drug Targets in Giardia lamblia | PLOS Neglected Tropical Diseases
Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors | SpringerLink
Solved A model binding site for ATP was created for | Chegg.com
ISL interacted with the ATP-binding site of VEGFR-2 kinase domain.
Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity | PNAS
Pharmaceuticals | Free Full-Text | Discovery of a Novel Template, 7-Substituted 7-Deaza-4′-Thioadenosine Derivatives as Multi-Kinase Inhibitors
Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase - Organic & Biomolecular Chemistry (RSC Publishing)
Model of the ATP-binding site of protein kinases. ATP is depicted in... | Download Scientific Diagram
Figure 1 from De Novo Design of Protein Kinase Inhibitors by in Silico Identification of Hinge Region-Binding Fragments | Semantic Scholar
ATP Binding Proteins - Jena Bioscience
Approaches to discover non-ATP site kinase inhibitors - MedChemComm (RSC Publishing)
Structure of a typical protein kinase domain displaying ATP binding... | Download Scientific Diagram
Pharmacophore model of ATP binding site. | Download Scientific Diagram
Mechanism of substrate specificity of phosphatidylinositol phosphate kinases | PNAS
Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery
Dual roles of ATP-binding site in protein kinases: Orthosteric inhibition and allosteric regulation - ScienceDirect
A) ATP binding site region and ATP interactions with the hinge... | Download Scientific Diagram
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors | Molecular Pharmacology
Tie2 kinase inhibitor, ATP-binding site-targeting Tie2 kinase inhibitor. Cell-permeable. (CAS 948557-43-5) (ab141270)
Molecules | Free Full-Text | Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases
File:Binding of ATP to kinase active site of EGFR.svg - Wikimedia Commons
Structure of ATP binding domain of protein kinases. | Download Scientific Diagram
Kinase Inhibitors | Cambridge MedChem Consulting
ATP Binding Proteins - Jena Bioscience
